WHAT AFFECTS THE SURVIVAL OF PATIENTS WHO UNDERGO COMPLETE RESECTION FOR STAGE IIIA-N2 NON-SMALL CELL LUNG CANCER?

被引：0
|
作者：
Gomez, Ana M. [1 ]
Hernando, Florentino [1 ]
Torres, Antonio J. [1 ]
Lopez Garcia-Asenjo, Jose A. [1 ]
Fernandez, Cristina [1 ]
Calatayud, Joaqun [1 ]
Jarabo, Jose R. [1 ]
Fernandez, Elena [1 ]
机构：
[1] Hosp Clin San Carlos, Madrid, Spain
来源：
JOURNAL OF THORACIC ONCOLOGY | 2011年 / 6卷 / 06期
关键词：
Stage IIIA; Complete resection; NSCLC; N2-disease;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
下载
收藏
页码：S654 / S654
页数：1
相关论文
共 50 条
  • [41] Effect of the number of lymph nodes examined on the survival of patients with stage I non-small cell lung cancer who undergo sublobar resection
    Yendamuri, Sai
    Dhillon, Samjot Singh
    Groman, Adrienne
    Dy, Grace
    Dexter, Elisabeth
    Picone, Anthony
    Nwogu, Chukwumere
    Demmy, Todd
    Hennon, Mark
    JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2018, 156 (01): : 394 - 402
  • [42] Neoadjuvant ceritinib treatment achieved pathological complete response in patients with anaplastic lymphoma kinase positive stage IIIA-N2 non-small cell lung cancer
    Shen Qian
    Gao Qiqi
    Zhou Jianying
    中华医学杂志(英文版), 2023, 136 (07)
  • [43] Optimal sequencing of postoperative radiotherapy and chemotherapy in IIIA-N2 non-small cell lung cancer
    Selek, Ugur
    Chang, Joe Y.
    JOURNAL OF THORACIC DISEASE, 2016, 8 (07) : 1394 - 1397
  • [44] Risk of Pneumonectomy or Bilobectomy after Neoadjuvant Concurrent Chemoradlotherapy for Stage IIIA-N2 Non-Small Cell Lung Cancer
    Cho, Jong Ho
    Choi, Yong Soo
    Shim, Young Mog
    Kim, Kwhanmien
    Kim, Jhingook
    Park, Keunchil
    Ahn, Yong Chan
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S375 - S375
  • [45] Neoadjuvant ceritinib treatment achieved pathological complete response in patients with anaplastic lymphoma kinase positive stage IIIA-N2 non-small cell lung cancer
    Shen, Qian
    Gao, Qiqi
    Zhou, Jianying
    CHINESE MEDICAL JOURNAL, 2023, 136 (07) : 851 - 853
  • [46] Postoperative Radiotherapy in Completely Resected IIIA-N2 Non-small Cell Lung Cancer: Quit or Not?
    Chen, Yu
    Yu, Jinming
    Meng, Xiangjiao
    ONCOLOGIST, 2023, 28 (05): : 376 - 378
  • [47] Risk factors of brain metastases in completely resected pathological stage IIIA-N2 non-small cell lung cancer
    Xiao Ding
    Honghai Dai
    Zhouguang Hui
    Wei Ji
    Jun Liang
    Jima Lv
    Zongmei Zhou
    Weibo Yin
    Jie He
    Luhua Wang
    Radiation Oncology, 7
  • [48] What is the optimal treatment of stage IIIA-N2 non-small-cell lung cancer after EORTC 08941?
    Van Meerbeeck, Jan P.
    De Pauw, Rebecca
    Tournoy, Kurt
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (02) : 199 - 206
  • [49] Selection of proper candidates with resected pathological stage IIIA-N2 non-small cell lung cancer for postoperative radiotherapy
    Hui, Zhouguang
    Dai, Honghai
    Liang, Jun
    Lv, Jima
    Zhou, Zongmei
    Feng, Qinfu
    Xiao, Zefen
    Chen, Dongfu
    Zhang, Hongxing
    Yin, Weibo
    Wang, Luhua
    THORACIC CANCER, 2015, 6 (03) : 346 - 353
  • [50] Value of postoperative radiotherapy for stage IIIa-N2 non-small cell lung cancer: an analysis based on SEER database
    Yang, Ran
    Gong, Jun
    Liao, Zhengkai
    Yu, Jing
    Zhang, Junhong
    Xie, Conghua
    TRANSLATIONAL CANCER RESEARCH, 2022, 11 (07) : 2194 - +
12345